Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein, in Formula 1, M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2, wherein X1 is C or N; X10 is C(R10) or N, X11 is C(R11) or N, X12 is C(R12) or N, X13 is C(R13) or N, X14 is C(R14) or N, X15 is C(R15) or N, X16 is C(R16) or N, X17 is C(R17) or N, X18 is C(R18) or N, and X19 is C(R19) or N; at least one of R2 comprises fluorine; b2 is an integer from 1 to 6; * and *? each indicate a binding site to M1; and the remaining descriptions of Formulae 1A and 1B are as provided herein.

Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein, M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2, wherein X1 is C or N, X2 is C or N, X3 is C or N, X4 is C or N, Y1 is O, S, Se, C(R5)(R6), N(R7), or Si(R8)(R9), two or more of R13 to R16 are linked to each other to form a substituted or unsubstituted C5-C30 carbocyclic group or a substituted or unsubstituted C1-C30 heterocyclic group, and the remaining substituent groups of Formulae 1A and 1B are as described herein.

Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein, M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2, wherein X1 is C or N; and X2 is C or N; Y1 is O, S, or Se; ring CY1 is a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; * and *? each indicate a binding site to M1; and the remaining substituent groups are as defined herein.

Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein, in Formula 1, M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2: wherein, X1 is C or N, X2 is C or N, Y1 is O, S, Se, C(R41)(R42), or N(R43), at least one R2 is a C1-C10 alkyl group that is substituted with a fluorine, b2 is an integer from 1 to 6, b11 is 1 or 2, b12 is an integer from 1 to 4, * and *? each indicate a binding site to M1, and the other substituent groups in Formulae 1A and 1B are as described herein.

Abstract: An organometallic compound represented by Formula 1: M1(L1)n1(L2)n2??Formula 1 wherein, M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2, wherein X1 is C or N; X2 is C or N; X3 is C or N; X4 is C or N; ring CY1 and ring CY2 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; Z1 and Z2 are each independently —Si(Q1)(Q2)(Q3) or —Ge(Q1)(Q2)(Q3); a1 and a2 are each independently an integer from 0 to 10; a sum of a1 and a2 is 1 or greater; Y1 and Y2 are each independently O, S, Se, N(R51), B(R52), C(R53)(R54), Si(R55)(R56), or Ge(R57)(R58); and the remaining substituent groups are as described herein.